Jianfan Bio has been awarded "GEM Value Top 50" for three consecutive years, which fully demonstrates the capital market's continuous recognition of Jianfan Bio and its confidence in its future development. At present, Jianfan Biological in the GEM listed companies in the total market capitalization ranked 20, 2017 to 2019 the company's operating income compound growth rate of 38.10%, net profit compound growth rate of 41.35%, the last three years have maintained a good operating results and rapid growth, the main business profitability and profitability level is outstanding, this time once again won the award is deserved.